Professional Recognition and Awards
- Forbes Best-in-State Wealth Management Teams 2023, 2024, 2025, 20261
William Blair Private Wealth Management

Professional Recognition and Awards
William Blair is a premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 30 offices worldwide.*
Year William Blair was founded
Employees worldwide
Client assets
Independent and employee-owned
Offices worldwide*
Companies under coverage
As of June 30, 2026
*Includes strategic alliances with Allier Capital, BDA Partners, and Poalim Equity Ltd.



William Blair initiated research coverage of Surrozen, Inc. (SRZN $24.00), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions.
William Blair initiated research coverage of Enliven Therapeutics, Inc. (ELVN $58.82), a late-stage biotech focused on developing ELVN-001, a potent and selective tyrosine kinase inhibitor (TKI), for the treatment of chronic myeloid leukemia (CML).
This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.
Copyright © 2026 William Blair & Company, L.L.C. | Privacy Notice
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures